Zaltrap

Novartis sues Regeneron over manufacturing methods
Biopharma Dive
Thu, 03/29/18 - 09:14 pm
Novartis
Regeneron
drug manufacturing
Zaltrap
Eylea
The 3 Most Disappointing Drug Launches of All Time
Motley Fool
Sun, 08/23/15 - 11:49 am
drug launches
MannKind
Afrezza
Sanofi
Zaltrap
Vivus
Arena Pharmaceuticals
Qsymia
Belviq
FDA Approves Sanofi SA's and Regeneron Pharmaceuticals Inc's Zaltrap for Metastatic Colorectal Cancer
Reuters
Fri, 06/6/14 - 10:08 am
FDA
Sanofi
Regneron
Zaltrap
colorectal cancer
Final NICE guidance rejects Sanofi's Zaltrap in colorectal cancer
First Word Pharma
Tue, 03/25/14 - 08:06 am
NICE
Sanofi
colorectal cancer
Zaltrap
Why Regeneron Pharmaceuticals Has A Bright Future Ahead
Seeking Alpha
Tue, 02/11/14 - 08:52 am
Regeneron
Arcalyst
Eylea
Zaltrap
3 Drug Disappointments From 2012
Motley Fool
Wed, 12/26/12 - 09:33 pm
Zaltrap
Sanofi
Amarin
Vascepa
Qsymia
Arena Pharmaceuticals
10 top drug launch disasters
Fierce Pharma
Wed, 11/28/12 - 11:13 am
drug launches
Rare Disease Therapeutics
Anascorp
AstraZeneca
Brilinta
Somaxon
Silenor
Sanofi
Multaq
Savient
Krystexxa
XenoPort
Horizant
Human Genome Sciences
Benlysta
Zaltrap
Dendreon
Provenge
KV Pharmaceutical
Makena
Sanofi Wins EU Backing for Drugs Against Diabetes, Cancer
Bloomberg
Sat, 11/17/12 - 01:42 pm
Lyxumia
diabetes
Zaltrap
colorectal cancer
This Top-Dollar Drug Hits the Discount Rack
Motley Fool
Sat, 11/17/12 - 01:27 pm
Sanofi
Dendreon
Regeneron
Zaltrap
Sanofi Wins EU Backing for New Drugs Against Diabetes and Cancer
Bloomberg
Fri, 11/16/12 - 10:43 am
Sanofi
Europe
diabetes
Zaltrap
colorectal cancer
Lyxumia
Sanofi Halves Price of Cancer Drug Zaltrap After Sloan-Kettering Rejection
NY Times, NY
Thu, 11/8/12 - 10:22 pm
drug pricing
Sanofi
Sloan Kettering
colon cancer
Zaltrap
Sanofi: A Long-Term Winner On These FDA Approvals
Seeking Alpha
Thu, 09/20/12 - 10:58 am
Sanofi
FDA
Aubagio
Zaltrap
3 Drugs Approved, but Only 1 Matters
Motley Fool
Tue, 08/7/12 - 11:43 am
FDA
drug approvals
Regeneron
Arcalyst
Eyelea
Novartis
Sanofi
Zaltrap
Why Regeneron May Not Profit Much From Today's FDA Approval
Forbes
Sat, 08/4/12 - 12:07 pm
Regeneron
Zaltrap
colorectal cancer
FDA approves Sanofi/Regeneron colon cancer drug
Reuters
Fri, 08/3/12 - 02:24 pm
FDA
Sanofi
Regeneron
colon cancer
Zaltrap
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Wed, 04/18/12 - 12:11 pm
BB1608
Boston Biomedical
Dainippon Sumitomo
cabozantinib
Exelixis
ONYX Pharmaceuticals
Carfilzomib
Medivation
Astellas
Enzalutamide
Ariad Pharmaceuticals
Ponatinib
Bayer
regorafenib
Oncovex
Amgen
Roche
Genentech
T-DM1
Immunogen
Aveo
tivozanib
Zaltrap
Sanofi
Regeneron
Priority Review for Zaltrap
Yahoo/Zacks
Thu, 04/5/12 - 09:12 pm
Zaltrap
Regeneron
Sanofi
colorectal cancer
Sanofi Singles Out Top Pipeline Prospects, New Cost Cuts
Motley Fool
Tue, 09/6/11 - 12:17 pm
Sanofi
Genzyme
Kynamro
Visamerin/Mulsevo
Zaltrap
Lemtrada
Aubagio
Lyxumia
Regeneron's VENICE Study to Continue
Yahoo/Zacks
Sat, 07/9/11 - 10:58 am
Regeneron
Zaltrap
prostate cancer
Sanofi
Sanofi, Regeneron report progress with cancer drug
Marketwatch
Mon, 06/6/11 - 09:18 am
Sanofi
Regeneron
Zaltrap
colorectal cancer

Pages